Machine learning

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Transforming drug discovery with AI and digital labs

A new free to attend webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning

Transforming drug discovery with AI and digital labs

In this FREE TO ATTEND webinar, hosted by DDW and supported by Sapio Sciences, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational methods, AI, and machine learning are revolutionising drug discovery. Dr Kumar highlights how Schrödinger’s physics-based simulations and Free Energy… Read More

Webinar date:
Supported by Sapio Sciences
#Webinars

#Artificial intelligence (AI) #Computational chemistry #Data science #Lab technology #Machine learning

Five potential problems with overhyping AI in drug discovery

Lucy Sabin, Postdoctoral Researcher at the University of Sheffield’s Information School reports on a study that examines how computational and medicinal chemists in drug discovery feel about AI. Whilst they are positive about AI methods in the field, they‘re calling for more realistic expectations. A growing number of pharmaceutical companies… Read More

#Exclusive Content

#Artificial intelligence (AI) #DDW Turning Science into Business Summit #Drug discovery #Events #Machine learning

‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery

Watch the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. The DDW ‘Turning Science into Business’ AI & ML summit sees experts and thought leaders in AI describe the… Read More

Webinar date:
Sponsored by The Jackson Laboratory
#Webinars

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Electronic Lab Notebooks (ELN) #Lab analytics #Lab of the future #Machine learning

New podcast on tools that support drug discovery and development

This is the latest episode of the free DDW narrated podcast, titled “Critical tools that support drug discovery and development”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “You think you need an ELN… but are you asking the… Read More

#News

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Drug targets #Interview #Machine learning

New podcast: The continued evidence of AI’s drug discovery value

This is the latest episode of the free DDW narrated podcast, titled “The continued evidence of AI’s drug discovery value”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “How generative AI could improve drug discovery” and “Can… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Laboratory data #Machine learning #Whitepaper

Whitepaper – Standardising data: Why do it and how?

Standardisation is critical to extracting the full potential of analytical data – in facilitating data-driven science and AI/ML-powered innovation. A new whitepaper entitled ‘Standardization of Analytical Data: Best Practices‘ is now available to download for free. The whitepaper will help you: Review currently available standard formats Understand the pros… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Laboratory data #Machine learning

Standardising data: Why do it and how?

Standardisation is critical to extracting the full potential of analytical data – in facilitating data-driven science and AI/ML-powered innovation. This whitepaper will help you: Review currently available standard formats Understand the pros and cons of open and proprietary formats Ensure data is adequately prepared for scientists and AI/ML applications… Read More

#Resources

#Artificial intelligence (AI) #Cellular imaging #Generative AI #Laboratory data #Machine learning

How AI and ML empower a new world of drug discovery

David Gosalvez, Head of Product Strategy and Zev Wisotsky, Senior Principle Marketing Manager for Biologics at Revvity Signals, highlight how three powerful AI and ML capabilities are driving lab innovation: enhancing data accessibility, enabling intelligent chemical reaction recommendations, and automating complex cellular imaging. Enhancing data accessibility with generative AI A… Read More

#Exclusive Content

#2025 predictions #Artificial intelligence (AI) #Drug discovery #Lab technology #Machine learning

Tech, ML and AI: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Here, the focus is on technology, machine learning (ML) and artificial intelligence (AI). In a prediction piece written for Forbes, contributor Bernard Marr outlined five key technology trends for 2025 across multiple industries1. With… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

Brain physiology
#Amyotrophic lateral sclerosis (ALS) #Artificial intelligence (AI) #Longitude Prize #Machine learning #Motor neuron disease #Neurology #Neuroscience

Third global Longitude Prize to be launched in 2025 focusing on ALS

The Longitude Prize series from Challenge Works will launch the Longitude Prize on amyotrophic lateral sclerosis (ALS) in Spring 2025. The next installment in the prize series follows the success of the Longitude Prize on antimicrobial resistance (AMR), won in 2024 by Sysmex Astrego’s PA-100 AST system, and the Longitude… Read More

#News

AI concept
#Artificial intelligence (AI) #Cradle #Drug discovery #Funding #Machine learning #Protein engineering

Generative AI unlock the impact of engineered biology

Cradle, an AI-powered platform for protein engineering, has raised $73m in Series B funding to respond to rising demand in R&D intensive industries. This funding takes the total raised to date over $100m. The round was led by IVP with participation from previous investors Index Ventures and Kindred Capital. Proteins… Read More

#Business & Investment #News

#Brain cancer #Genetic profiling #Machine learning #Oncology #Precision medicine #UCLA

ML study identifies new glioblastoma treatment strategy

A new precision medicine approach that combines genetic and functional profiling could predict how glioblastoma will respond to therapy.  A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma becomes resistant to treatment and introduces a new approach that paves… Read More

#Cancer Research #Editor's Choice #News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

Download the report: How AI and ML are improving drug discovery

Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can utilise to bring therapies to patients. Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free… Read More

#News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

AI and ML: How technology is improving drug discovery

Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free In Focus report available to download now. Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence